EX-12.2 5 a2225154zex-12_2.htm EX-12.2

Exhibit 12.2

 

Agile Therapeutics, Inc.

Computation of Ratio of Earnings to Combined Fixed Charges and Preferred Stock Dividends

For the Three Months Ended March 31, 2015 and Years Ended December 31, 2014, 2013 and 2012

(Dollars in thousands)

 

 

 

Three Months

 

 

 

 

 

 

 

 

 

Ended

 

Year Ended December 31,

 

 

 

March 31, 2015

 

2014

 

2013

 

2012

 

Earnings:

 

 

 

 

 

 

 

 

 

Pretax loss from continuing operations

 

$

(8,538

)

$

(19,730

)

$

(14,321

)

$

(23,260

)

Add:

 

 

 

 

 

 

 

 

 

Fixed charges

 

426

 

1,566

 

1,513

 

140

 

 

 

 

 

 

 

 

 

 

 

Total Earnings

 

$

(8,112

)

$

(18,164

)

$

(12,808

)

$

(23,120

)

 

 

 

 

 

 

 

 

 

 

Fixed Charges:

 

 

 

 

 

 

 

 

 

Interest expensed, including amortized discounts and premiums

 

$

426

 

$

1,566

 

$

1,513

 

$

140

 

Estimate of interest expense within rental expense

 

—

 

—

 

—

 

—

 

Preferred Stock Dividends

 

—

 

—

 

—

 

—

 

 

 

 

 

 

 

 

 

 

 

Total Fixed Charges

 

$

426

 

$

1,566

 

$

1,513

 

$

140

 

 

 

 

 

 

 

 

 

 

 

Ratio of Earnings to Fixed Charges

 

n/a

 

n/a

 

n/a

 

n/a

 

 

 

 

 

 

 

 

 

 

 

Deficiency of Earnings Available to Cover Fixed Charges

 

$

(8,538

)

$

(19,730

)

$

(14,321

)

$

(23,260

)